TREM2 and Alzheimer disease: For example, a missense mutation (R47H) in triggering receptor expressed in myeloid cells 2 (TREM2), a cell surface protein highly and selectively expressed on microglia, was found to increase the risk of AD approximately three-fold [54, 55].